Načítá se...
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
BACKGROUND: The muscle invasive form of urothelial bladder cancer (UBC) is a deadly disease. Currently, the therapeutic approach of UBC is mostly based on surgery and standard chemotherapy. Biomarkers to establish appropriate drugs usage are missing. Deficiency of the tumor suppressor CCDC6 determin...
Uloženo v:
| Vydáno v: | J Exp Clin Cancer Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6381716/ https://ncbi.nlm.nih.gov/pubmed/30786932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1087-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|